Physician profile
Jason Edward Kappa
NPI 1124413976
$43,566.11
in general payments reported to CMS, 2019-2025
9 companies · $997 in 2025
The $997 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $1,250 · 2021: $39K · 2022: $476 · 2023: $1,373 · 2024: $660 · 2025: $997.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,941 · Travel and Lodging: $1,089.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,940.60 |
| Travel and Lodging | $1,089.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $25,470.27 | 2021-2025 | Arthrex |
| Medinc of Texas | $8,978.64 | 2021-2025 | |
| Djo, LLC | $5,000.00 | 2021 | |
| Smith+Nephew, INC. | $2,684.97 | 2020-2023 | Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Stryker Corporation | $794.14 | 2021-2025 | Mako, Omega, Blueprint Patient Specific Instrumentation |
| Exactech, INC. | $186.73 | 2021 | |
| Innovation Technologies INC | $167.04 | 2022 | |
| Anika Therapeutics, INC. | $159.32 | 2022 | |
| Vericel Corporation | $125.00 | 2024 | Maci |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Kappa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.